PDF Print E-mail

The 9th SABPA Entrepreneur Symposium:

 

Bringing Novel Therapeutics from Concept to Market

 

- A Case Study in Regenerative Medicine


When
: 5:00 pm to 8:00 pm, Saturday, April 16th, 2011

Where: Institute of Americas , UCSD (Parking is free at Pangea)

Registration: http://sabpa.org/web/news_details.php?ID=322

Lecture Title: “Bringing Novel Therapeutics from Concept to Market--A Case Study in Regenerative Medicine”

Lecture Summary: In this lecture, Dr. Gail Naughton will discuss the following topics:

- Why biomedical discovery?
- Hurdle to market
- Tissue engineering
- Road to commercialization
- Financial reality: Many issues
- Biotech product development & external funding

Speaker: Gail K. Naughton, Ph.D., CEO and Chairman, Histogen, Inc.
In addition to being the Dean of the College of Business Administration at San Diego State University since 2002, Dr. Naughton founded Histogen, Inc. in 2007, and currently serves as CEO and Chairman of the Board for the Company. She oversaw the development of four tissue engineered products through to market launch and was pivotal in raising over $350 Million US dollars from both public markets and corporate partnership. Dr. Naughton has spent more than 15 years extensively researching the process of tissue engineering, holds over 95 U.S. and foreign patents and has been extensively published in the field.